Heart health study for kids starting a type of chemotherapy
Part of Injuries & trauma clinical trials.
This study checks how a common chemotherapy drug (anthracycline) affects the heart in children. It will monitor heart function during treatment to help protect young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 18 years old (child or teen).
- You have not had this type of chemotherapy before.
- You have not had a bone marrow transplant or chest radiation.
- Your heart function is normal before starting treatment.
- An echo shows no serious fluid or valve problems in your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how anthracycline chemotherapy affects the heart and blood vessels in children and teens who had cancer. It aims to help doctors better understand long-term heart risks and follow-up care.
This study looks at how chemotherapy and other cancer treatments affect the heart in children. It aims to find heart problems early so they can be treated quickly.
This study uses heart imaging scans and blood tests to check if a common cancer drug (anthracycline) is affecting your heart during treatment. Early detection might help doctors protect your heart health.
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
This trial tests whether a medication can prevent heart damage in children and teens receiving chemotherapy. It is for patients aged 2 to 18 who can take oral medication.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
Hear when a new Heart Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.